Natalizumab: from theory to practical cases Prof. Johann Sellner
We will discuss:
- Natalizumab in the treatment of MS – theory and evidence
- Real-world case studies – what would you do?
Your presenters
Prof. Johann Sellner
Prim. Univ. Prof. Dr. Johann Sellner
Professor of Neurology
Landesklinikum Mistelbach-Gänserndorf, Austria
Prof. Johann Sellner
Prim. Univ. Prof. Dr. Johann Sellner
Professor of Neurology
Landesklinikum Mistelbach-Gänserndorf, Austria
You can find more information about the processing of your personal data by visiting Privacy policy and clicking on “Healthcare Professionals Privacy Notice
This webinar has been fully funded and organised by Biogen. Biogen products will be discussed at this meeting. The latest version of all Summary of Product Characteristics issued by the European Medicines Agency can be found at: https://www.ema.europa.eu/en/medicines Please consult your locally approved information before prescribing a medicinal product.
© 2021 Biogen. Biogen-82624 – February 2021